UBS analyst Jay Sole downgrades Victoria’s Secret (NYSE:VSCO) from Neutral to Sell.
Kymera Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Kymera Therapeutics…